Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas
Authors:
- Panteleimon KountourakisPKPanteleimon Kountourakis
- Kitty PavlakisKPKitty Pavlakis
- Amanda PsyrriAPAmanda Psyrri
- Dimitra RontogianniDRDimitra Rontogianni
- Nikolaos XirosNXNikolaos Xiros
- Efstratios PatsourisEPEfstratios Patsouris
- Dimitrios PectasidesDPDimitrios Pectasides
- Theofanis EconomopoulosTETheofanis Economopoulos
Open Access
- 28 February 2006
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 6 (1) , 46
Abstract
Background: Colorectal cancer remains a major cause of cancer mortality in the Western world. A limited number of studies has been conducted in respect of Her-3 and Her-4 expression and their correlation with clinical parameters and prognosis in colorectal carcinomas . In this study we sought to determine the pattern and the prognostic significance of HER-3 and HER-4 in colorectal adenocarcinoma. Methods: We studied HER-3 and HER-4 protein expression in106 paraffin embedded specimens of primary colorectal tumors using immunohistochemistry. The pattern and protein expression levels of HER-3 and HER-4 were correlated with several clinical and pathological parameters. Results: HER-3 staining displayed membranous and cytoplasmic expression pattern in 18 (17%) and 30 samples (28,3%), respectively. HER-4 membranous and cytoplasmic expression was found in 20 (18,9%) and 32 samples (30,2%), respectively. Specimens regarded as positive for HER-3 cytoplasmic expression were associated with moderate tumor grade (p = 0,032) and older median age (p = 0,010). Specimens regarded as positive for HER-4 membranous protein expression were associated with involved lymphnodes (p = 0,0003). Similar results were obtained when considering Her-3 and Her-4 protein expression irrespective of their cellular localization. There was no correlation between the expression of HER-3 and HER-4 and patients outcome. Conclusion: HER-4 membranous protein expression was found to predict for lymph nodes positivity in this cohort of patients with colorectal cancer.HER-4 expression status may identify tumors with aggressive biological behavior and increased metastatic potential.Keywords
This publication has 29 references indexed in Scilit:
- HER‐2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumorsInternational Journal of Cancer, 2003
- HER 2/neu expression and gene amplification in colon cancerInternational Journal of Cancer, 2003
- Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast CancerJournal of Clinical Oncology, 2002
- The EGFR family and its ligands in human cancerEuropean Journal of Cancer, 2001
- The ErbB signaling network: receptor heterodimerization in development and cancerThe EMBO Journal, 2000
- Expression of the Tyrosine Kinase Activity Growth Factor Receptors (EGFR, ERB B2, ERB B3) in Colorectal Adenocarcinomas and AdenomasTumor Biology, 2000
- C-erbB-2 immunostaining: problems with interpretation.Journal of Clinical Pathology, 1994
- The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot studyEuropean Journal of Cancer, 1993
- Immunocytochemical localization of c‐erbB‐2 protein in transitional cell carcinoma of the urinary bladderThe Journal of Pathology, 1993
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987